August 21, 2023 — How much might the application of new insights from the SELECT study of treating obesity do for preventing heart attacks, strokes, and deaths. A first pass at answering this question appeared in Cardiovascular Drugs and Therapy last week. Nathan Wong, Hridhay Karthikeyan, and Wenjun Fan estimated the potential for semaglutide treatment to lower cardiovascular disease […]
June 29, 2023 — After four exhilarating days of new possibilities for overcoming diabetes and obesity at ADA2023, we had to come back down to earth. The National Institute for Health and Clinical Excellence in the UK stepped up to this task right away. On Tuesday, NICE said nope to recommending tirzepatide use for type 2 diabetes in the […]
April 14, 2023 — For decades, we’ve watched growth in the prevalence of obesity and the chronic diseases it causes. Health systems have profited from treating those downstream diseases. Without really thinking about it, public health policy and payers have conspired to deny care for the root cause of those diseases – obesity. Bias inspired some of this because […]
